StockData
Nautilus Biotechnology, Inc. logo

Nautilus Biotechnology, Inc. (NAUT) stock

NAUTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 6/30
$2.43+0.07 (+2.97%)

Close on Nov 18, 2026Market cap $309.52MP/E –Yield –

Nautilus Biotechnology market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Nautilus Biotechnology's market cap was $307.88M on Nov 11, 2026, against $284.19M a year earlier. Over the last 5 years it ranged from $85.89M to $643.18M, with a median of $319.82M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$307.88M+25.0%
2025Dec 31, 2025$246.29M+16.8%
2024Dec 31, 2024$210.94M-43.5%
2023Dec 29, 2023$373.57M+66.4%
2022Dec 30, 2022$224.50M-65.1%
2021Dec 31, 2021$643.18M–

More Nautilus Biotechnology figures

See a number that looks wrong?